Financial Credibility Became Reputation Infrastructure

Reputation is no longer built through branding alone. Governance, transparency, and operational integrity now define how organizations are perceived externally.

The New Era Of Preventive Medicine: Advancing BHRT And Pharmacy Compounding Awareness In The Philippines

The growing focus on preventive medicine highlights how personalized care is reshaping the future of healthcare in the Philippines.

TESDA, Nestlé Philippines Join Forces To Empower Coffee Farmers Through Skills Development

Technical Education and Skills Development Authority and Nestlé Philippines strengthen their partnership to support coffee farmers through skills development and sustainable livelihood programs.

The BE Group Secures COREnergy Partnership To Energize Mabuhay Towers

The BE Group of Companies partners with COREnergy to improve energy management across Mabuhay Towers in Cebu.

EU Meets 70% Vaccination Target By July

The European Union reached its target of vaccinating 70 percent of its adult population with at least one jab by July, the bloc’s top official confirmed Tuesday.

EU Meets 70% Vaccination Target By July

51
51

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The European Union reached its target of vaccinating 70 percent of its adult population with at least one jab by July, the bloc’s top official confirmed on Tuesday.

“The EU has kept its word and delivered,” Ursula von der Leyen, the president of the European Commission, announced in a video statement.

At least 57 percent of adults have already been fully vaccinated, she added.

Von der Leyen also warned of the dangers of the highly contagious Delta variant and urged everyone who has not been inoculated yet to get their jabs.

The European Commission set in March the objective to vaccinate 70 percent of the adult population — a minimum to reach herd immunity — by July.

The jabs were provided in the framework of bloc’s advanced purchase agreements with six vaccine producers — Pfizer/BioNTech, Moderna, AstraZeneca, CureVac, Johnson & Johnson, and Sanofi/GlaxoSmithKline — to buy about 2.6 billion vaccine doses.

In addition, the European Commission agreed with Pfizer/BioNTech to purchase another 1.8 billion doses for 2022 and 2023. (PNA)